by
Sean Ruck, Contributing Editor | October 16, 2018
From the October 2018 issue of HealthCare Business News magazine
The 60th annual ASTRO meeting will highlight several practice-changing clinical trials that will impact cancer care around the world almost immediately. Look in particular for powerful new clinical trial results that will come forth in head and neck cancer, breast cancer, lung cancer and prostate cancer.
The Director of the National Cancer Institute (NCI), Dr. Ned Sharpless will provide a high profile Keynote Address that will illuminate current and future visions for the NCI.
Community oncologists will find a valuable new program at the 2018 ASTRO meeting that provides valuable tips and practice approaches to assist in their daily cancer practice.
And these highlights only scratch the surface for ASTRO’s 60th Annual Meeting in San Antonio this October. We encourage HCB News readers to follow the meeting online using the hashtag #ASTRO18.
HCB News: Is there any advice you can offer for someone looking to join ASTRO?
PH: Join now, even while you are a medical student with a developing interest in the field of oncology. This early glimpse into the world of cancer research and clinical care will capture your enthusiasm and engage your professional interest for a lifetime.
HCB News: Can you give your prediction as to how you think radiation oncology will change over the next 10 years?
PH: During the next 10 years, radiation oncology will be characterized by even greater precision, increased cure rates, diminished side effects, more effective and durable palliation, increased cost effectiveness and an expanding role in the multidisciplinary world of cancer care.
Back to HCB News
